Literature DB >> 32517156

Evaluation of Rapid Extraction Methods Coupled with a Recombinase Polymerase Amplification Assay for Point-of-Need Diagnosis of Post-Kala-Azar Dermal Leishmaniasis.

Rajashree Chowdhury1, Prakash Ghosh1, Md Anik Ashfaq Khan1, Faria Hossain1, Khaledul Faisal1, Rupen Nath1, James Baker1, Ahmed Abd El Wahed2, Shomik Maruf1,3, Proggananda Nath4, Debashis Ghosh1, Md Masud-Ur-Rashid5, Md Utba Bin Rashid1, Malcolm S Duthie6, Dinesh Mondal1.   

Abstract

To detect Post-kala-azar leishmaniasis (PKDL) cases, several molecular methods with promising diagnostic efficacy have been developed that involve complicated and expensive DNA extraction methods, thus limiting their application in resource-poor settings. As an alternative, we evaluated two rapid DNA extraction methods and determined their impact on the detection of the parasite DNA using our newly developed recombinase polymerase amplification (RPA) assay. Skin samples were collected from suspected PKDL cases following their diagnosis through national guidelines. The extracted DNA from three skin biopsy samples using three different extraction methods was subjected to RPA and qPCR. The qPCR and RPA assays exhibited highest sensitivities when reference DNA extraction method using Qiagen (Q) kit was followed. In contrast, the sensitivity of the RPA assay dropped to 76.7% and 63.3%, respectively, when the boil & spin (B&S) and SpeedXtract (SE) rapid extraction methods were performed. Despite this compromised sensitivity, the B&S-RPA technique yielded an excellent agreement with both Q-qPCR (k = 0.828) and Q-RPA (k = 0.831) techniques. As expected, the reference DNA extraction method was found to be superior in terms of diagnostic efficacy. Finally, to apply the rapid DNA extraction methods in resource-constrained settings, further methodological refinement is warranted to improve DNA yield and purity through rigorous experiments.

Entities:  

Keywords:  DNA extraction; point-of-need diagnosis; post-kala-azar dermal leishmaniasis (PKDL); real-time PCR; recombinase polymerase amplification (RPA)

Year:  2020        PMID: 32517156     DOI: 10.3390/tropicalmed5020095

Source DB:  PubMed          Journal:  Trop Med Infect Dis        ISSN: 2414-6366


  5 in total

1.  An Optimized Real-Time qPCR Method for the Effective Detection of Human Malaria Infections.

Authors:  Saiful Arefeen Sazed; Mohammad Golam Kibria; Mohammad Shafiul Alam
Journal:  Diagnostics (Basel)       Date:  2021-04-21

2.  One Health and Neglected Tropical Diseases-Multisectoral Solutions to Endemic Challenges.

Authors:  Jennifer K Peterson; Jared Bakuza; Claire J Standley
Journal:  Trop Med Infect Dis       Date:  2020-12-29

Review 3.  Isothermal Nucleic Acid Amplification to Detect Infection Caused by Parasites of the Trypanosomatidae Family: A Literature Review and Opinion on the Laboratory to Field Applicability.

Authors:  Denis Sereno; Bruno Oury; Anne Geiger; Andrea Vela; Ahmed Karmaoui; Marc Desquesnes
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

4.  A Multi-Country, Single-Blinded, Phase 2 Study to Evaluate a Point-of-Need System for Rapid Detection of Leishmaniasis and Its Implementation in Endemic Settings.

Authors:  Prakash Ghosh; Abhijit Sharma; Narayan Raj Bhattarai; Kumar Abhishek; Thilini Nisansala; Amresh Kumar; Susanne Böhlken-Fascher; Rajashree Chowdhury; Md Anik Ashfaq Khan; Khaledul Faisal; Faria Hossain; Md Rasel Uddin; Md Utba Rashid; Shomik Maruf; Keshav Rai; Monica Sooriyaarachchi; Withanage Lakma Kumari Abhayarathna; Prahlad Karki; Shiril Kumar; Shalindra Ranasinghe; Basudha Khanal; Satyabrata Routray; Pradeep Das; Dinesh Mondal; Ahmed Abd El Wahed
Journal:  Microorganisms       Date:  2021-03-12

5.  Evaluation of molecular assays to detect Leishmania donovani in Phlebotomus argentipes fed on post-kala-azar dermal leishmaniasis patients.

Authors:  Md Anik Ashfaq Khan; Khaledul Faisal; Rajashree Chowdhury; Rupen Nath; Prakash Ghosh; Debashis Ghosh; Faria Hossain; Ahmed Abd El Wahed; Dinesh Mondal
Journal:  Parasit Vectors       Date:  2021-09-09       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.